Literature DB >> 15827152

Gamma interferon-dependent, noncytolytic clearance of sindbis virus infection from neurons in vitro.

Rebeca Burdeinick-Kerr1, Diane E Griffin.   

Abstract

Due to the nonrenewable nature of neurons, recovery from viral infection of the central nervous system requires noncytopathic mechanisms for control of virus replication. Recovery from alphavirus encephalitis can occur without apparent neurological damage through the effects of antibody and gamma interferon (IFN-gamma). To establish an in vitro cell culture system that will allow the study of mechanisms of IFN-gamma-mediated control of Sindbis virus (SINV) replication in neurons, we have characterized the susceptibility to SINV infection and IFN-gamma responsiveness of two neuronal cell lines that can be differentiated in vitro: CSM14.1, a rat nigral cell line, and NSC34, a mouse motor neuron cell line. Undifferentiated CSM14.1 and NSC34 cells were permissive for SINV and susceptible to virus-induced cell death. With differentiation, CSM14.1 cells reduced virus replication and became progressively resistant to virus-induced cell death, resulting in prolonged virus replication. NSC34 cells did not differentiate completely and became only partially resistant to SINV infection. Both CSM14.1 and NSC34 cells responded to pretreatment with IFN-gamma by decreasing SINV replication. Differentiated CSM14.1 cells treated 24 h after infection with IFN-gamma responded with increased cell viability and clearance of infectious virus. IFN-gamma treatment sequentially altered the ratio of genomic to subgenomic viral RNA synthesis, promoted recovery of cellular protein synthesis, reduced viral protein synthesis, and inhibited viral RNA transcription within 24 h after treatment. We conclude that CSM14.1 cells provide an excellent model for the study of IFN-gamma-mediated noncytolytic clearance of SINV from mature neurons.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15827152      PMCID: PMC1082728          DOI: 10.1128/JVI.79.9.5374-5385.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Sindbis virus infection in man. Report of a case with recovery of virus from skin lesions.

Authors:  H MALHERBE; M STRICKLAND-CHOLMLEY; A L JACKSON
Journal:  S Afr Med J       Date:  1963-05-25

Review 2.  How cells respond to interferons.

Authors:  G R Stark; I M Kerr; B R Williams; R H Silverman; R D Schreiber
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

3.  Regulation of Sindbis virus RNA replication: uncleaved P123 and nsP4 function in minus-strand RNA synthesis, whereas cleaved products from P123 are required for efficient plus-strand RNA synthesis.

Authors:  Y Shirako; J H Strauss
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

4.  Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways.

Authors:  A Zhou; J M Paranjape; S D Der; B R Williams; R H Silverman
Journal:  Virology       Date:  1999-06-05       Impact factor: 3.616

5.  Characterization of an in vitro model of alphavirus infection of immature and mature neurons.

Authors:  Patty S Vernon; Diane E Griffin
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

6.  Cell surface expression of MHC molecules in glioma cells infected with herpes simplex virus type-1.

Authors:  G Y Song; G DeJong; W Jia
Journal:  J Neuroimmunol       Date:  1999-01-01       Impact factor: 3.478

7.  Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T cell response.

Authors:  S L Wesselingh; B Levine; R J Fox; S Choi; D E Griffin
Journal:  J Immunol       Date:  1994-02-01       Impact factor: 5.422

8.  Viral determinants of age-dependent virulence of Sindbis virus for mice.

Authors:  P C Tucker; E G Strauss; R J Kuhn; J H Strauss; D E Griffin
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

9.  Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons.

Authors:  N R Cashman; H D Durham; J K Blusztajn; K Oda; T Tabira; I T Shaw; S Dahrouge; J P Antel
Journal:  Dev Dyn       Date:  1992-07       Impact factor: 3.780

10.  bcl-2 inhibits death of central neural cells induced by multiple agents.

Authors:  L T Zhong; T Sarafian; D J Kane; A C Charles; S P Mah; R H Edwards; D E Bredesen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

View more
  51 in total

1.  Treatment with cationic liposome-DNA complexes (CLDCs) protects mice from lethal Western equine encephalitis virus (WEEV) challenge.

Authors:  Christopher H Logue; Aaron T Phillips; Eric C Mossel; Jeremy P Ledermann; Thomas Welte; Steve W Dow; Ken E Olson; Ann M Powers
Journal:  Antiviral Res       Date:  2010-05-07       Impact factor: 5.970

Review 2.  Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.

Authors:  Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection.

Authors:  James D Brien; Jennifer L Uhrlaub; Janko Nikolich-Zugich
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

4.  Distinct Immune Responses in Resistant and Susceptible Strains of Mice during Neurovirulent Alphavirus Encephalomyelitis.

Authors:  Kirsten A Kulcsar; Victoria K Baxter; Rachy Abraham; Ashley Nelson; Diane E Griffin
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

5.  Inefficient type I interferon-mediated antiviral protection of primary mouse neurons is associated with the lack of apolipoprotein l9 expression.

Authors:  Marguerite Kreit; Sophie Paul; Laurent Knoops; Aurélie De Cock; Frédéric Sorgeloos; Thomas Michiels
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

6.  Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis.

Authors:  Sivabalan Manivannan; Victoria K Baxter; Kimberly L W Schultz; Barbara S Slusher; Diane E Griffin
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

7.  Synergistic roles of antibody and interferon in noncytolytic clearance of Sindbis virus from different regions of the central nervous system.

Authors:  Rebeca Burdeinick-Kerr; Jennifer Wind; Diane E Griffin
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

8.  Noncytolytic clearance of sindbis virus infection from neurons by gamma interferon is dependent on Jak/STAT signaling.

Authors:  Rebeca Burdeinick-Kerr; Dhanasekaran Govindarajan; Diane E Griffin
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

Review 9.  Recovery from viral encephalomyelitis: immune-mediated noncytolytic virus clearance from neurons.

Authors:  Diane E Griffin
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

10.  Protection from fatal viral encephalomyelitis: AMPA receptor antagonists have a direct effect on the inflammatory response to infection.

Authors:  Ivorlyne P Greene; Eun-Young Lee; Natalie Prow; Brownhilda Ngwang; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.